[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 263
Citations 0
Comment & Response
August 9, 2016

Cost of Antihyperglycemic Medications in the United States—Reply

Author Affiliations
  • 1School of Population and Global Health, University of Melbourne, Victoria, Australia
  • 2School of Public Health, University of Michigan, Ann Arbor, Michigan
JAMA. 2016;316(6):665-666. doi:10.1001/jama.2016.8596

In Reply Like many other analyses of the costs of diabetes in the United States,1 our study relied on MEPS, which collects data from pharmacies on the costs of medications. The survey does not account for rebates, which involve payments by pharmaceutical companies to payers and intermediaries including pharmacy benefit managers,2 because these rebates are generally not publicly disclosed.

First Page Preview View Large
First page PDF preview
First page PDF preview
×